Neurology
Parkinson’s Is Trying to Vaccinate Against Progression
A Phase II alpha-synuclein vaccine generated antibodies in every treated participant and reached the cerebrospinal fluid. The immune response is real. Whether it changes Parkinson’s disease is still unanswered.
Down Syndrome Cannot Be Alzheimer’s Afterthought
Alzheimer’s Diagnosis Gets Another Gate
Progressive MS Still Needs Repair, Not Relapse Logic
Pregnancy Is Now an ADHD Care Gap
Parkinson’s Gets Fast Track, Not Fast Proof
Anxiety Gets a Psychedelic Trial, Not a Shortcut
Antidepressant Trials Still Leave People Out
ALS Biomarkers Are Entering the Approval Fight
Stroke Recovery Needs More Than Scans and Scores
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
Diseases in Neurology
Explore disease data and country profiles on the IPM Alliance platform.
Explore diseases